D G Ohara1, M S Pegorari, N L Oliveira Dos Santos, C de Fátima Ribeiro Silva, M S R Oliveira, A P Matos, M Jamami. 1. Maycon Sousa Pegorari, Federal University of Amapá, Department of biological and health sciences, Physical Therapy Course. Address: Road Juscelino Kubitschek, Km - 02, Jardim Marco Zero, Macapá - AP, CEP 68903-419 - Phone number: (+55 96) 4009-2944 E-mail: mayconpegorari@yahoo.com.br.
Abstract
OBJECTIVES: To compare the obtained and expected values of pulmonary function variables between sarcopenic and non-sarcopenic elderly; verify the association between the pulmonary function and the indicators and diagnosis of sarcopenia; and establish cut-off points for pulmonary function variables to predict sarcopenia. DESIGN: Cross-sectional study. LOCATION: Macapá, Brazil. PARTICIPANTS: community-dwelling elderly ≥ 60 years old (n=383), both sexes. MEASURES: Were evaluated according to variables of pulmonary function (spirometry) and sarcopenia, according to the EWGSOP consensus. The association between pulmonary function and sarcopenia was performed using logistic regression and cut-off points established from the ROC Curve. RESULTS: The prevalence of sarcopenia was 12.53% (n = 48). Sarcopenic individuals had significantly lower mean values for FVC, FEV1, FEF25-75% and PEF than non-sarcopenic. After adjustment, spirometric variables were inversely associated with sarcopenia (the increase by one unit of liter in FVC, FEV1 and FEF25-75% decreased the probability of sarcopenia by 59%, 67% and 39%, respectively), and the majority of these variables with the muscular strength indicator. Cut-off points, for elderly men and women, were discriminant criteria for the presence of sarcopenia: FVC (≤2.52 L and ≤1.82 L), FEV1 (≤2.1 L and ≤1.39 L), PEF (≤3.45 L/s and ≤2.93 L/s) and FEF5-75% (≤1.97 L/s and ≤1.74 L/s). CONCLUSIONS: There was loss of pulmonary function in sarcopenic elderly patients and an inverse association with the diagnosis of sarcopenia and its indicators. Cut-off points of pulmonary function variables can be used as a useful tool to discriminate sarcopenia.
OBJECTIVES: To compare the obtained and expected values of pulmonary function variables between sarcopenic and non-sarcopenic elderly; verify the association between the pulmonary function and the indicators and diagnosis of sarcopenia; and establish cut-off points for pulmonary function variables to predict sarcopenia. DESIGN: Cross-sectional study. LOCATION: Macapá, Brazil. PARTICIPANTS: community-dwelling elderly ≥ 60 years old (n=383), both sexes. MEASURES: Were evaluated according to variables of pulmonary function (spirometry) and sarcopenia, according to the EWGSOP consensus. The association between pulmonary function and sarcopenia was performed using logistic regression and cut-off points established from the ROC Curve. RESULTS: The prevalence of sarcopenia was 12.53% (n = 48). Sarcopenic individuals had significantly lower mean values for FVC, FEV1, FEF25-75% and PEF than non-sarcopenic. After adjustment, spirometric variables were inversely associated with sarcopenia (the increase by one unit of liter in FVC, FEV1 and FEF25-75% decreased the probability of sarcopenia by 59%, 67% and 39%, respectively), and the majority of these variables with the muscular strength indicator. Cut-off points, for elderly men and women, were discriminant criteria for the presence of sarcopenia: FVC (≤2.52 L and ≤1.82 L), FEV1 (≤2.1 L and ≤1.39 L), PEF (≤3.45 L/s and ≤2.93 L/s) and FEF5-75% (≤1.97 L/s and ≤1.74 L/s). CONCLUSIONS: There was loss of pulmonary function in sarcopenic elderly patients and an inverse association with the diagnosis of sarcopenia and its indicators. Cut-off points of pulmonary function variables can be used as a useful tool to discriminate sarcopenia.
Entities:
Keywords:
Sarcopenia; aging; forced expiratory volume; pulmonary function tests; spirometry
Authors: Y K Jeon; M J Shin; M H Kim; J H Mok; S S Kim; B H Kim; S-J Kim; Y K Kim; J H Chang; Y B Shin; I J Kim Journal: Osteoporos Int Date: 2015-05-09 Impact factor: 4.507
Authors: Anne B Newman; Varant Kupelian; Marjolein Visser; Eleanor Simonsick; Bret Goodpaster; Michael Nevitt; Stephen B Kritchevsky; Frances A Tylavsky; Susan M Rubin; Tamara B Harris Journal: J Am Geriatr Soc Date: 2003-11 Impact factor: 5.562
Authors: D G Ohara; M S Pegorari; N L Oliveira Dos Santos; C de Fátima Ribeiro Silva; R L Monteiro; A P Matos; M Jamami Journal: J Nutr Health Aging Date: 2018 Impact factor: 4.075
Authors: Alfonso J Cruz-Jentoft; Jean Pierre Baeyens; Jürgen M Bauer; Yves Boirie; Tommy Cederholm; Francesco Landi; Finbarr C Martin; Jean-Pierre Michel; Yves Rolland; Stéphane M Schneider; Eva Topinková; Maurits Vandewoude; Mauro Zamboni Journal: Age Ageing Date: 2010-04-13 Impact factor: 10.668
Authors: Y Rolland; S Czerwinski; G Abellan Van Kan; J E Morley; M Cesari; G Onder; J Woo; R Baumgartner; F Pillard; Y Boirie; W M C Chumlea; B Vellas Journal: J Nutr Health Aging Date: 2008 Aug-Sep Impact factor: 4.075
Authors: Renata Ferrari; Laura M O Caram; Marcia M Faganello; Fernanda F Sanchez; Suzana E Tanni; Irma Godoy Journal: Int J Chron Obstruct Pulmon Dis Date: 2015-08-06
Authors: R Menozzi; F Valoriani; F Prampolini; F Banchelli; E Boldrini; F Martelli; S Galetti; R Fari'; S Gabriele; P Palumbo; D Forni; M Pantaleoni; R D'Amico; A R Pecchi Journal: Clin Nutr ESPEN Date: 2021-12-07